Bristol-Myers Squibb Company (NYSE:BMY) will host a teleconference on Friday, October 31, 2014, at 2:30 p.m. EDT (1:30 p.m. CDT) to review data presented at the Chicago Multidisciplinary Symposium on Thoracic Oncology (CMSTO) in Chicago. Company executives will provide an overview of data presented at the meeting, with a focus on the company’s immuno-oncology portfolio, and address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live webcast of the call at: http://investor.bms.com or by dialing 647-788-4901, conference code: 19907013. Materials related to the call will be available at the same website prior to the call. A replay of the call will be available beginning at 3:30 p.m. EDT on October 31, 2014 through 1:59 EST on November 11, 2014. The replay can be accessed at http://investor.bms.com or by dialing 404-537-3406, confirmation code: 19907013.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.
Contacts:
Media:
Laura
Hortas, 609-252-4587
laura.hortas@bms.com
or
Investors:
John
Elicker, 609-252-4611
john.elicker@bms.com
or
Ranya
Dajani, 609-252-5330
ranya.dajani@bms.com
or
Ryan
Asay, 609-252-5020
ryan.asay@bms.com